Taste loss to terbinafine: A case-control study of potential risk factors

被引:30
作者
Stricker, BHC
VanRiemsdijk, MM
Sturkenboom, MCJM
Ottervanger, JP
机构
[1] INSPECTORATE HLTH CARE,DRUG SAFETY UNIT,RIJSWIJK,NETHERLANDS
[2] DEPT PHARMACOEPIDEMIOL & PHARMACOTHERAPY,UTRECHT,NETHERLANDS
[3] ERASMUS UNIV ROTTERDAM,SCH MED,DEPT INTERNAL MED 2,ROTTERDAM,NETHERLANDS
关键词
taste; terbinafine; antimycotic;
D O I
10.1046/j.1365-2125.1996.04105.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 To identify risk factors associated with taste loss to terbinafine, we performed a case-control study of 87 reports of probable terbinafine-induced taste loss and 362 controls on terbinafine without taste loss, who had filled prescriptions from the same pharmacy and GP. Data on general health, diet, alcohol, smoking, drug use and medical history were collected by means of a self-administered questionnaire. 2 The mean latent period between first intake of terbinafine and taste loss was 35 days. Most patients recovered within 4 months after discontinuation. Cases were significantly older than controls. The odds ratio of taste loss in patients of 65 years and older was 4.4 in comparison with persons younger than 35 years of age (95% CI: 1.4-16.1). The risk in persons with a body mass index (BMI) below 21 kg m(-2) was 4.4 times higher than in those with a BMI of more than 27 kg m(-2) (95% CI: 1.6-14.2). The risk of taste loss in patients of 55 years and older with a BMI below 21 kg m(-2) was 12.8 times higher than that in patients below 35 years of age (95% CI: 1.9-88.6). 3 A low BMI, a history of taste loss, and ageing are risk factors for developing taste loss to terbinafine. Prescription of this drug to elderly patients with low BMI and low daily intake of nutrients requires careful follow-up.
引用
收藏
页码:313 / 318
页数:6
相关论文
共 25 条
[1]   TERBINAFINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN SUPERFICIAL MYCOSES [J].
BALFOUR, JA ;
FAULDS, D .
DRUGS, 1992, 43 (02) :259-284
[2]   TASTE DISORDERS AND TERBINAFINE [J].
BEUTLER, M ;
HARTMANN, K ;
KUHN, M ;
GARTMANN, J .
BRITISH MEDICAL JOURNAL, 1993, 307 (6895) :26-26
[3]  
DAVIDSON S, 1979, HUMAN NUTRITION DIET, P237
[4]  
GOLDBOHM RA, 1994, THESIS MAASTRICHT U
[5]  
HULSHOF KFA, 1986, V86547160513 CIVO TN
[6]   A CASE-CONTROL STUDY OF DIET AND COLO-RECTAL CANCER [J].
JAIN, M ;
COOK, GM ;
DAVIS, FG ;
GRACE, MG ;
HOWE, GR ;
MILLER, AB .
INTERNATIONAL JOURNAL OF CANCER, 1980, 26 (06) :757-768
[7]   LOSS OF TASTE AND TERBINAFINE [J].
JUHLIN, L .
LANCET, 1992, 339 (8807) :1483-1483
[8]  
Kahn H. A, 1989, MONOGRAPHS EPIDEMIOL, V12
[9]   DOSE-PROPORTIONAL PHARMACOKINETICS OF TERBINAFINE AND ITS N-DEMETHYLATED METABOLITE IN HEALTHY-VOLUNTEERS [J].
KOVARIK, JM ;
KIRKESSELI, S ;
HUMBERT, H ;
GRASS, P ;
KUTZ, K .
BRITISH JOURNAL OF DERMATOLOGY, 1992, 126 :8-13
[10]  
KOVARIK JM, 1992, N-S ARCH PHARMACOL, V346, pR37